Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma
Year: 2021
Type: article
Abstract: Transforming growth factor beta (TGFβ) and programmed death-ligand 1 (PD-L1) are often overproduced in refractory squamous cell carcinoma (SCC). We examined spatial patterns of PD-L1+ cells in mouse and human SCCs and found that PD-L1 was primarily expressed on infiltrating leukocytes. Although combined TGFβ and PD-L1 blockade are undergoing cancer clinical trials, there are no predictive markers for therapeutic responders. To address this, we used both a small molecule TGFβ inhibitor in combination with anti-PD-L1 and a bifunctional fusion protein targeting both TGFβ and PD-L1 to treat mouse SCCs and found TGFβ inhibition enhanced PD-L1 blockade-induced tumor eradication in multiple tumor models. Furthermore, we identified distinct cell populations of responders and non-responders to bintrafusp alfa, with responders showing a shift toward a more immune-permissive microenvironment. The cellular and molecular signatures of responders versus non-responders to combined TGFβ and PD-L1 blockade provide important insights into future personalized immunotherapy in SCC.
Source: Communications Biology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,290
Funders: U.S. Department of Health and Human Services, U.S. Department of Veterans Affairs, Merck KGaA, National Institutes of Health, EMD Serono, Cancer Center, University of Colorado, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Dental and Craniofacial Research
Awards: Mechanisms underlying therapy failure of immune checkpoint inhibitors and Notch1 loss-mediated immunosuppression in head and neck cancers, G1565180698, G1566029328, G2107073222, Training in Translational Research of Lung, Head and Neck Cancer, Identifying oral cancer stem cell properties affected by the microenvironment, Predoctoral Training Grant in Pharmacology, G516621933, G5520316217, G7654855663, Mechanisms of Dual Inhibition of TGFbeta/PD-L1 in HNSCC, Elucidating Mechanism of Immune Evasion in Head and Neck Cancers, Training in Translational Research of Skin Diseases, University of Colorado Cancer Center Support Grant
OpenAlex ID: W3194058828
